Companies Mentioned

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, Plc.)

Category
Title
Summary
Date
Commentaries
Patent Law

In an effort to attack its notorious backlog, the USPTO enacted a group of rule changes that placed limits on, among other things, the number of claims a patent applicant could include and the number of times an applicant could amend and continue his application. Traditionally, patent applicants could take…
Posted:
05/12/2008
Summaries
Patent Law >
New Judicial Opinions

Plaintiffs Smithkline Beecham Corporation d/b/a GlaxoSmithKline, et al. (collectively, “GSK”) and Triantafyllos Tafas (“Tafas”) instituted this lawsuit pursuant to the Administrative Procedure Act (the “APA”) to permanently enjoin defendants Jon W. Dudas and the USPTO from enacting the “Changes to Practice for Continued Examination Filings, Patent Applications Containing Patentably Indistinct…
Date of ruling:
04/1/2008
The most advanced document                
         management system in the world.

Only $59 / person / month
FeaturesLawLoop Demo
FeaturesWelcome to the Future
Play LawLoop Demo